E
ZYUS Life Sciences Corporation ZLSCF
$0.60 -$0.06-9.09%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income 8.11% 47.96% 30.75% -307.55% 44.67%
Total Depreciation and Amortization -6.71% 18.57% -22.13% 485.46% -32.18%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 282.81% -95.89% -89.43% 462.55% -105.88%
Change in Net Operating Assets 127.90% 363.51% -182.16% 1,519.65% -384.07%
Cash from Operations 82.91% 91.23% -62.26% -54.20% -299.34%
Capital Expenditure 68.97% 100.00% 29.01% 29.06% 61.73%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- 100.00% --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 68.97% -100.00% 29.01% 36.58% 61.73%
Total Debt Issued -- -97.87% -- -100.00% -100.00%
Total Debt Repaid -371.32% 97.28% -459.02% -111.39% -197.84%
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 281.33% -98.03% -114.32% -115.27% -125.39%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 94.76% -100.81% -525.76% -5,852.93% -11,985.19%
Weiss Ratings